À Propos de l'Entreprise
- Raison sociale: OMGENE LIFE SCIENCES PRIVATE LIMITED
- Pays d'enregistrement: India
- Adresse: 333/334, GIDC Makarpura,, Makarpura GIDC, Vadodara, Gujarat
- Nombre d'employés: 100 - 249
Description:
Omgene Life Sciences Pvt. Ltd., an R&D-based company incorporated in March 2011, has operated in the biopharmaceutical space since its founding by Dr. A.L. Prasad, a highly skilled, experienced pharmaceutical technocrat with around 30 years of industrial track record, leading an R&D team of more than 100 highly skilled professionals. Omgene is a fast-growing Indian company engaged in developing, manufacturing and marketing peptides, oligonucleotides, semi-synthetic and synthetic APIs, and recombinant molecules.
Activités Commerciales
Principes Actifs Pharmaceutiques (API)
Fabricant de Principes Actifs (API)
Services de sous-traitance & d’externalisation
Fabricant de Principes Actifs (API)
Équipements de Production & Utilités Industrielles
Fabricant de Principes Actifs (API)
API de Référence (Princeps)
Fabricant de Principes Actifs (API)
Marchés de Vente
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Western Asia: United Arab Emirates, Armenia, Azerbaijan, Bahrain
Produits/Services Clés
- Principes Actifs Pharmaceutiques (API): Triptorelin Acetate, Fulvestrant, Liraglutide, Binimetinib, Omadacycline, Erdafitinib, Everolimus, Ixazomib Citrate, Midostaurin, Sugammadex Sodium, Tirzepatide, Vasopressin, Cetrorelix Acetate, Degarelix Acetate, Carbetocin, Etelcalcetide, Ganirelix Acetate, Lanreotide Acetate, Leuprolide Acetate, Linaclotide, Octreotide Acetate, Oxytocin Acetate, Pentetreotide, Plecanatide, Terlipressin Acetate, Rezafungin, Apremilast, Bedaquiline Fumarate, Brivaracetam, Crisaborole, Deutetrabenazine, Ribociclib Succinate, Mebendazole (Micronized), Nintedanib Esylate, Nitisinone, Obeticholic acid, Rufinamide, Sarecycline Hydrochloride, Selexipag, Tofacitinib Citrate, Vismodegib
- Services de sous-traitance & d’externalisation: Complex Semi-synthetic APIs
Nos Produits & Services
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Certifications
Proofs
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
Évaluations
(0)
(0)
(0)
(0)
(0)
Commentaires
Filtres :
Trier par :
Aucun commentaire disponible.
Laissez votre note & commentaire